Prognostic and Diagnostic Significance of circRNA Expression in Esophageal Cancer: A Meta-analysis

Table 4

Clinical parameters of circRNAs in esophageal cancer.

Parameters	Tumor promoter			Tumor suppressor
	OR	95% CI		OR	95% CI
Age (old/young)	1.096	(0.701, 1.713)	0.688	1.147	(0.427, 3.083)	0.786
Gender (M/W)	0.961	(0.660, 1.399)	0.835	1.201	(0.369, 3.909)	0.761
Tumor size (large/small)	1.68	(1.031, 2.738)	0.037	2.214	(0.792, 6.190)	0.13
Differentiation grade	1.02	(0.673, 1.545)	0.925	2.708	(0.559, 13.115)	0.216
TNM stage (/)	2.214	(0.713, 6.876)	0.169	2.891	(1.052, 7.949)	0.04
T classification (/)	1.729	(1.074, 2.785)	0.024	—	—	—
Lymph node metastasis (Y/N)	4.657	(1.951, 11.112)	0.001	—	—	—
Distant metastasis (Y/N)	8.47	(0.594, 120.694)	0.115	—	—	—

CI, confidence interval; M, men; N, no; W, women; Y, yes; OR, odds ratio; na, not available. The results are in bold if .